APA (7th ed.) Citation

Dhillon, M., Kobashigawa, J. A., Kittleson, M., Jain, R., Patel, N., Singer‐Englar, T., . . . Patel, J. K. (2024). Does bortezomib influence pre‐transplant desensitization therapy or benefit post‐heart transplant outcomes for highly sensitized patients? Clinical Transplantation, 38(1), 1. https://doi.org/10.1111/ctr.15165

Chicago Style (17th ed.) Citation

Dhillon, Manvir, et al. "Does Bortezomib Influence Pre‐transplant Desensitization Therapy or Benefit Post‐heart Transplant Outcomes for Highly Sensitized Patients?" Clinical Transplantation 38, no. 1 (2024): 1. https://doi.org/10.1111/ctr.15165.

MLA (9th ed.) Citation

Dhillon, Manvir, et al. "Does Bortezomib Influence Pre‐transplant Desensitization Therapy or Benefit Post‐heart Transplant Outcomes for Highly Sensitized Patients?" Clinical Transplantation, vol. 38, no. 1, 2024, p. 1, https://doi.org/10.1111/ctr.15165.